Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.

Ryder Washington needs a bone marrow transplant. But the five-year-old, like many other African-Americans, doesn’t have any matches in the national bone marrow registry. His parents are out to change that.

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.

In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.

When Dan Wagner’s leukemia came back, he was devastated. Now he’s celebrating five years’ cancer-free, thanks to his donor and new life-long friend.

While it plays a protective role in other diseases, knocking out NLRP6 in mice led to better outcomes, less-severe symptoms after bone marrow transplant.

A study at the University of Michigan suggests we can prevent graft-versus-host disease by bolstering the amount of the microbiome-derived metabolite butyrate.